Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 2:10 AM
Ignite Modification Date: 2025-12-26 @ 12:37 AM
NCT ID: NCT03345160
Description: All 7 subjects reported mild symptoms with at least one IP administration. These reactions were collected and reported as AEs. These allergic reactions were expected.
Frequency Threshold: 0
Time Frame: 52 weeks
Study: NCT03345160
Study Brief: Peanut Oral Immunotherapy in Children: IMPACT Follow Up Study
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Peanut Flour: Open Label Peanut OIT This is an open label treatment for subjects who had previously received placebo treatment in a prior peanut OIT study Peanut Flour: open label oral immunotherapy 0 None 0 7 7 7 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Mild allergic reaction-Initial Dose Escalation SYSTEMATIC_ASSESSMENT General disorders None View
Asthma Exacerbation SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders None View
Rhinitis SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders None View
Allergic Conjunctivitis SYSTEMATIC_ASSESSMENT Eye disorders None View
Strept Throat SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders None View
Sinusitis SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders None View
GERD-not related to dosing SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View
Mild allergic reaction-Dosing related SYSTEMATIC_ASSESSMENT General disorders None View
Gastroenteritis SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View
influenza SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders None View
Otitis Media SYSTEMATIC_ASSESSMENT Ear and labyrinth disorders None View
upper respiratory infection SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders None View
Fever SYSTEMATIC_ASSESSMENT General disorders None View
Cough SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders None View
Eczema Flare SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders None View
Vomiting-not associated with dosing SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View
Nausea-not associated with dosing SYSTEMATIC_ASSESSMENT General disorders None View
Pneumonia SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders None View
Wrist Fracture SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders None View
Allergic Reaction -not related to dosing SYSTEMATIC_ASSESSMENT General disorders None View
Otitis Externa SYSTEMATIC_ASSESSMENT Ear and labyrinth disorders None View
Back pain-related to a fall SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders None View
Rash-not related to dosing SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders None View
Dehydration SYSTEMATIC_ASSESSMENT General disorders None View
Sore Throat SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders None View
Constipation SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View